ISSN: 2376-127X

妊娠と小児の健康に関するジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

インデックス付き
  • 索引コペルニクス
  • Google スカラー
  • アカデミックキー
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • ICMJE
このページをシェアする

抽象的な

Who Caesarean Section Rate: Relevance and Ubiquity at the Present Day – A Review Article

Susana Teixeira, Humberto S Machado*

Background: In 1985 the World Health Organization (WHO) claimed that there were no reasons for any region in the world to have a caesarean section (CS) rate above 10-15%. Even so, many of the developed countries present superior CS rate. Although CS rate rise in countries with high maternal and neonatal morbi-mortality is benefice, doubts exist about countries that already present a high CS rate, because some concern exist that above a certain limit, the risks are superior to the benefits. The aim of this review is to analyse the CS rate in different countries and to determinate if the WHO limit can be applied to all. Also to compare the maternal and neonatal morbidity and mortality between vaginal and CS birth, trying to evaluate the best way to deliver. Methods: Data about CS rate, maternal mortality, neonatal mortality and Human Development Index (HDI) was collected from official reports and scientific papers. Results: The world CS rates varies from 1.5% in Ethiopia to 56.6% in Brazil. The rate is superior in countries with high HDI, and inferior in poor countries. In general, countries with high CS rate present a low maternal and neonatal mortality. The opposite is observed in poor countries. Conclusion: Since the WHO declaration many changes occurred in society, in the women status and in medicine, making us question if the 15% limit is still updated. The different social-economic, cultural and ethnographic reality of each country suggests that a global CS rate should not exist. Instead, each country should adjust CS rate to its necessities and focus on providing this option to any women who needs it. Some evidence suggests that CS can have a higher maternal and neonatal morbi-mortality when compared with vaginal delivery, however it has also positive aspects that should be taken in consideration.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。